Showing results (1241-1250 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|September 26, 2019
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin TherapyHisamitsu Ishihara, Susumu Yamaguchi, Toshifumi Sugitani, et al.Clinical Drug Investigation|September 26, 2019
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male SubjectsDénes Csonka, Shirin Bruderer, Armin Schultz, et al.Clinical Drug Investigation|February 27, 2021
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral DensityPaul D Miller, Steven Troy, Richard J Weiss, et al.Clinical Drug Investigation|December 10, 2016
Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover StudyAndrew L Finn, Niraj Vasisht, Jeffrey G Stark, et al.Clinical Drug Investigation|December 9, 2016
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design StudyHelen Jenkins, Richard Jenkins, Alain PatatClinical Drug Investigation|March 29, 2017
Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot StudyRiyo Matsumura, Toshihiro Inoue, Akira Matsumura, et al.Clinical Drug Investigation|March 31, 2017
Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control TrialsSavino Sciascia, Elisa Mompean, Massimo Radin, et al.Clinical Drug Investigation|April 1, 2017
Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database AnalysisStephane Cheung, Yukinobu Hamuro, Jörg Mahlich, et al.Clinical Drug Investigation|April 1, 2017
Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in GermanyDavid Tamoschus, Katja Draexler, Jane Chang, et al.Clinical Drug Investigation|January 12, 2017
Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive PatientsFrancesco Saverio Mennini, Andrea Marcellusi, Lara Gitto, et al.Pageof 234